Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Thiomersal free trivalent influenza split vaccine 2003/2004 · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Group A | EXPERIMENTAL | Subjects aged between 6 months and 3 years. |
| Group B | EXPERIMENTAL | Subjects aged 3 to 6 years. |
| Group C | ACTIVE_COMPARATOR | Subjects aged between 6 months and 3 years. |
| Group D | ACTIVE_COMPARATOR | Subjects aged 3 to 6 years. |
| Name | Type | Description |
|---|---|---|
| Thiomersal free trivalent influenza split vaccine 2003/2004 | BIOLOGICAL | 2 doses, intramuscular injection |
| GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2003/2004 | BIOLOGICAL | 2 doses, intramuscular injection |
Inclusion Criteria: * Subjects whose parents/guardians the investigator believes can and will comply with the requirements of the protocol * Male or female children over 6 months of age at the time of vaccination, but who are not yet 6 years old. * All children included in the study must never have...